Stock Report

Download full stock data and analysis for free Last Updated: 30-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Align Technology (ALGN) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$144.01

up-down-arrow $-0.99 (-0.68%)

As on 29-Sep-2026 16:16EDT

Market cap

info icon

$10,427 Mln

Revenue (TTM)

info icon

$4,140 Mln

P/E Ratio

info icon

25.4

P/B Ratio

info icon

2.5

Div. Yield

info icon

0 %

Edit peer-selector-edit
Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Market cap ($ Mln)
 10,427 24,123 10,065 9,957 9,441
Revenue ($ Mln)
 4,140 17,664 2,589 3,145 3,054
Net Profit ($ Mln)
 413.58 1,114.00 222.40 535.46 375.30
Net Margin (%)
 9.99 6.31 8.59 17.03 12.29
RoE (%)
 9.99 9.93 3.04 11.46 25.55
Price to Earnings
 25.44 18.84 45.79 19.21 25.49
Price-To-Book
 2.49 1.83 1.43 2.12 15.03

Income Statement ($ Mln)

Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Operating Revenue arrow
4,139.53 17,664.00 2,589.30 3,144.90 3,053.50
Cost of Revenue arrow
1,387.59 9,551.00 1,245.50 989.14 883.10
Gross Profit arrow
2,756.90 8,058.00 1,343.60 1,981.10 1,939.90
Operating Expenses arrow
2,200.16 6,392.00 1,108.90 1,504.66 1,654.50
Operating Profit (EBIT) arrow
551.86 1,721.00 235.00 652.69 515.80
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
568.91 1,477.00 350.40 664.95 494.70
Provision for Tax arrow
155.33 364.00 128.00 129.49 119.30
Profit after Tax (Net Income) arrow
413.58 1,114.00 222.40 535.46 375.30
Minority Interest arrow
0.00 -2.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 579.00 378.10 0.00 0.00

Liabilities ($ Mln)

Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Shareholder's Funds arrow
4,232.45 11,447.00 7,173.90 4,768.60 1,422.20
Minority Interest arrow
0.00 -2.00 0.00 0.00 0.00
Non-Current Liabilities arrow
276.53 7,802.00 2,116.80 240.31 998.70
Current Liabilities arrow
1,908.60 7,423.00 961.30 479.35 744.20
Total Liabilities arrow
6,233.69 26,944.00 10,576.50 5,302.76 3,190.40

Assets ($ Mln)

Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Non-Current Assets arrow
3,754.53 17,371.00 7,231.50 3,272.75 1,316.00
Current Assets arrow
2,663.05 9,330.00 3,020.50 2,215.51 1,849.10
Total Assets arrow
6,233.69 26,944.00 10,576.50 5,302.76 3,190.40
Total Debt* arrow
120.84 7,465.00 1,203.70 111.19 948.40
Net Current Assets arrow
754.45 1,907.00 2,059.20 1,736.17 1,104.90

Cashflow ($ Mln)

Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Cash From Operating Activities arrow
593.22 1,162.00 532.20 753.45 569.30
Cash Flow from Investing Activities arrow
-112.45 -737.00 -189.70 -355.01 -222.70
Cash from Financing Activities arrow
-464.58 107.00 -283.20 -679.16 -595.30
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
ROCE (%) arrow
10.09 4.64 8.98 11.44 9.50
ROE (%) arrow
9.99 9.93 3.04 11.46 25.55
ROA (%) arrow
5.00 3.29 2.02 9.43 8.97
EBIT Margin (%) arrow
15.19 10.30 -5.99 15.11 13.73
Net Margin (%) arrow
9.99 6.31 8.59 17.03 12.29
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Revenue Growth (%) arrow
4.41 -1.08 1.37 19.74 29.41
EBIT Growth (%) arrow
-3.03 59.79 -131.06 36.96 30.76
Net Profit Growth (%) arrow
-5.49 587.65 -30.32 50.14 58.96
EPS Growth (%) arrow
-2.80 579.15 -29.66 50.51 66.81
Book Value Growth (%) arrow
9.63 8.94 2.19 9.65 -1.05

Valuation Ratios

 Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Price / Earnings arrow
27.31 29.23 10.77 22.27 81.29
Price / Book Value arrow
2.77 2.39 1.10 2.62 13.26
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
13.35 11.92 6.54 15.81 38.36
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Debt to Equity arrow
0.00 0.55 0.11 0.00 0.65
Short term debt to equity ratio arrow
0.01 0.10 0.06 0.00 0.01
Current Ratio arrow
1.40 1.26 3.14 4.62 2.48
Quick Ratio arrow
1.28 0.82 2.33 2.93 1.83
Interest Coverage arrow
364.75 5.06 8.18 97.52 8.80

Operating Efficiency Ratios

 Align Technology (ALGN) Koninklijke Philips N.V. NY Registry Shares - ADR Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED) Insulet (PODD)
Debtors to sales (%) arrow
27.74 20.36 17.06 23.51 19.28
Asset Turnover arrow
0.50 0.52 0.24 0.55 0.73
Receivable days arrow
99.00 73.75 65.39 82.15 59.51
Inventory Days arrow
68.68 113.36 221.09 270.47 209.92
Payable days arrow
32.89 70.18 37.02 33.17 22.54
Cash Conversion Cycle arrow
134.79 116.92 249.46 319.45 246.89
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...